Finance Business Partner - AstraZeneca - BU Respiratory

Meer details

What do you do?

At AstraZeneca, one of the world’s most forward-thinking and connected BioPharmaceutical companies, they are changing the future of medicine. A higher quality of life and longer life expectancy, despite a serious (chronic) illness. That's what AstraZeneca works very hard for worldwide. For the Respiratory Business Unit, we are looking for a Finance Business Partner who brings the same passion for changing people’s lives! In this position you report to the BU Director and work closely with the Brand Managers and multidisciplinary brand teams; existing of the commercial, marketing and medical teams. You are their financial business partner delivering key insights on performance and supporting strategic business decisions with (scenario) analysis, financial modelling and market insights. You have a strong working relationship with your peers within other BU’s and your colleagues within finance.

Together with the business determining the relevant drivers and KPI’s to track and ensuring structural insights using dashboarding and BI. Combining financial, commercial & operational data with external market data (IQVIA) to be able to do in-depth analysis on (top-line) performance, patient models, patient journey, market trends, market share, competitor strategies, activities & performance. Uncovering trends, emerging threats and opportunities for the business and provide insight, analysis and challenge when necessary to help drive and shape the performance of Respiratory NL.

As the Finance Business Partner you lead the Long Term (4y), Mid Term (1y) and Short Term planning & (re)forecasting process. Constructively challenging the commercial forecast and planning assumptions for the BU and add to resource allocation (investment decisions) based on credible insights, intelligence & analysis. Setting stretching but attainable targets that align to the organisations’ strategic and financial objectives. Furthermore, you manage the periodic management reporting, including an in-depth variance analysis and commentary on key drivers and developments. You will be part of the periodical business reviews with BU management, the Country President & CFO NL, in which you are able to convey your message in a clear and constructive manner.

Good to know

AstraZeneca has invested a lot in the development of new treatments for Respiratory illness and they have a promising pipeline. Next to the existing treatments available in NL new treatments will be launched in 2022 and beyond. You will be actively involved supporting the new market entry with insights, analysis, patient models and forecasting.

Who are you?

You bring the analytical capacity and eagerness to really understand and grasp the key drivers and complexity of the business in order to add value. You have a strong and informed opinion but listen and value the thoughts of others. Whenever necessary you are able to hold your ground, but in a constructive way which enables you to foster strong business relationships.

“We are looking for a financial with excellent analytical skills, who is able to handle large amounts of data and stimulates data-driven strategic decision making. Strong communication skills are key. We need somebody who understands and relates to both finance as well as commercial topics. Who connects the two and when necessary translates this in a simple, clear manner to create understanding and common ground. To do this well you have the natural ability to forge strong relations with a variety of different stakeholders.

Although the commercial side of the business is a big focus in the position, you never lose sight of the fact that we are here to make an impact on people’s lives. Getting the people the treatment they need will always come first and we are looking for somebody who is sincere and passionate about being able to contribute to our mission ”

  • Master degree in Finance, Economics or Accountancy
  • Minimum of 5 years of experience in FP&A, commercial or business control; preferably within the pharmaceutical / healthcare industry
  • King or Queen in Excel and preferably PowerBI. Experience with (competitor / market) research, large data sets & financial modelling
  • Strong communicator in English and preferable (social) Dutch; able to build and maintain relations on different levels both internally and externally
  • Excellent planning and organizational skills. Able to bring structure and focus in highly dynamic environment.
  • Think beyond the data to bring presentations to life, focusing on “story telling” and explaining complex issues in clear and impactful ways
  • Well-developed influencing skills with the ability to drive bigger picture thinking
  • Ambition, initiative, discipline, drive for results and customer focus

More about AstraZeneca

A higher quality of life and longer life expectancy, despite a serious (chronic) illness. That's what AstraZeneca works very hard for worldwide. We explore the boundaries of science to develop medicines that make a true difference for patients. Our medicines have a strong focus on oncology, cardiovascular, renal (kidney) and metabolic diseases (CVRM), respiratory and immune diseases. In addition, we are working with the University of Oxford to make the AstraZeneca COVID vaccine available worldwide.

Spread over six continents, 75.000 people work on ground-breaking science. In the Netherland we have our head office in The Hague. The colleagues there supervise clinical research, ensure that patients have access to our medicines, provide information and work closely with all stakeholders in healthcare industry to improve patient care. In addition, about 100 colleagues in Nijmegen make early clinical research possible and new medicines are being developed at Acerta Pharma in Oss, especially to treat blood cancer.

BU Respiratory & Immunology

AstraZeneca aims to transform the treatment of asthma and chronic obstructive pulmonary disease (COPD) by eliminating preventable asthma attacks across all severities and removing COPD as a leading cause of death through earlier, biology-led treatment.

With common pathways and underlying disease drivers across respiratory and immunology, we are following the science from chronic lung diseases to immune-driven diseases. Our ambition in immunology is to achieve disease control and ultimately clinical remission in targeted immune-driven diseases. Next to the existing treatments on the NL market available today, we are working on numerous promising treatments, of which several will enter the NL market next year.

Life at AstraZeneca

We’re curious about science and the advancement of knowledge. We find creative ways to approach new challenges. We’re driven to make the right choices and are accountable for our actions.

As an organisation centred around what makes us human, we put a big focus on people. Across our business, we want colleagues to wake up excited about their day at the office, in the field, or in the lab. Along with our purpose to bring life-changing medicines to people across the globe, we have a promise to you: to help you realise the full breadth of your potential. Here, you’ll do work that has the potential to change your life and improve countless others. And, together with your team, you’ll shape a culture that unites and inspires us every day.

Den Haag office

Around 200 dedicated colleagues work (partly) from the inspiring Den Haag office. A diverse mix of people, who share the same passion and energy to make a difference. The culture is open, supportive and ambitious. It is a high performance environment, but with the continuous focus on teamwork and a healthy (work/life) balance. The communication style is very open and transparent, you’ll experience a lot of commitment and inclusion. The mission is clear and shared during the periodic (external) kick-offs, but also at the (medical) Town hall meetings and patient weeks where the patients share their story. Then you truly experience what it’s all for.

Respiratory and Immunology - Our therapy areas - AstraZeneca

Salary

Competitive package

Publish date

22.12.2021

Contact

Wissink